Article
Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells
31 Jan 2019
Abstract excerpt
BACKGROUND AIMS: Delaying replicative senescence and extending lifespan of human mesenchymal stromal cells (MSCs) may enhance their potential for tissue engineering and cell based therapies. Accumulating evidence suggests that inhibitors of the mTOR signaling pathway, such as rapamycin, constitute promising pharmacological agents to retard senescence and extend stemness properties of various progenitor cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
